The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation Ref. No: JVAC-D-16-01124

Affiliations

¹ Immunisation and Blood Safety Department, Public Health England, 61 Colindale Avenue, London NW9 5EQ, United Kingdom. Electronic address: Julia.Stowe@phe.gov.uk.
² Statistics and Modelling Economics Unit, Public Health England, London NW9 5EQ, United Kingdom.
³ Immunisation and Blood Safety Department, Public Health England, 61 Colindale Avenue, London NW9 5EQ, United Kingdom.

Comment

Julia Stowe et al. Vaccine. 2016.

. 2016 Dec 7;34(50):6115.

doi: 10.1016/j.vaccine.2016.10.014.

¹ Immunisation and Blood Safety Department, Public Health England, 61 Colindale Avenue, London NW9 5EQ, United Kingdom. Electronic address: Julia.Stowe@phe.gov.uk.
² Statistics and Modelling Economics Unit, Public Health England, London NW9 5EQ, United Kingdom.
³ Immunisation and Blood Safety Department, Public Health England, 61 Colindale Avenue, London NW9 5EQ, United Kingdom.

No abstract available

Comment on

The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation.
Stowe J, Andrews N, Ladhani S, Miller E. Stowe J, et al. Vaccine. 2016 Jul 12;34(32):3684-9. doi: 10.1016/j.vaccine.2016.04.050. Epub 2016 Jun 7. Vaccine. 2016. PMID: 27286641
Intussusception risk after rotavirus vaccination in England.
Drysdale SB, Pollard AJ. Drysdale SB, et al. Vaccine. 2016 Dec 7;34(50):6114. doi: 10.1016/j.vaccine.2016.10.007. Vaccine. 2016. PMID: 27899198 No abstract available.